Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hinye Pharmaceutical, officially known as Zhejiang Hinye Pharmaceutical Co., Ltd., is a prominent Chinese pharmaceutical company and a key subsidiary of the Yangtze River Pharmaceutical Group. Based in Haining, Zhejiang Province, the company focuses on the research, development, and large-scale manufacturing of chemical drugs across various therapeutic areas, including cardiovascular, digestive, and respiratory systems. Hinye is well-regarded for its high-quality production standards and holds multiple GMP certifications, contributing significantly to its parent group's market leadership in China. Its product portfolio includes widely recognized medications such as amlodipine maleate and rabeprazole sodium. The company integrates advanced manufacturing technologies with a robust R&D framework to serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hinye Pharmaceutical.